SERIES ARTICLES
|
|
(1) Essential hypertension
Pharmaceutical Journal, 21 March 1998 |
|
(2) Sinusitis and otitis media
Pharmaceutical Journal, 13 June 1998 |
| (3) COPD
Chronic obstructive pulmonary disease
Pharmaceutical Journal, 5 Sep 1998 |
|
(4) Diabetes
Pharmaceutical Journal, 21 Nov 1998 |
|
(5) Chronic heart failure
Pharmaceutical Journal, 10 April 1999 |
|
(6) Gastro-oesophageal reflux disease
Gastro-oesophageal reflux disease is a common problem.
In some patients it is mild and self limiting but in others it can be
a chronic disorder with serious consequences. This article outlines the
condition and the evidence base for its treatment, before going on to
discuss how pharmaceutical care can be applied to improve clinical outcome.
(more)
Pharmaceutical Journal, 14 Aug 1999, p241-250. Vol 263, no 7058 |
|
(7) Arthritis
Arthritis, which includes osteoarthritis, inflammatory
arthritis and gout, affects about 10 per cent of the adult UK population,
although estimates of prevalence are made difficult by diagnostic uncertainties
(more)
Pharmaceutical Journal, 8 Jan 2000, p57-68. Vol 264, no 7078 |
|
(8) Asthma
Asthma is a common disease affecting 20 per cent of children
and 7 per cent of adults in the UK. This article examines the pharmaceutical
care of asthma. Areas covered include chronic asthma, problem asthma,
acute exacerbations of asthma, delivery devices used in the treatment
of the condition and the monitoring of asthma
(more)
Pharmaceutical Journal, 8 Apr 2000, p546-556. Vol 264, no 7091 |
|
(9) Coronary heart disease
Coronary heart disease affects 3.5 per cent of the UK
adult population. This article examines the pharmaceutical care of coronary
heart disease and covers primary and secondary prevention of the disease
and the treatment of angina
(more)
Pharmaceutical Journal, 5 Aug 2000, p194-205. Vol 265, no 7108 |
|
(10) Palliative care
Palliative care
is the care of any patient with advanced, incurable disease. It involves
the control of symptoms, such as pain, and aims to improve quality of life
for both patients and their families. This article specifically examines
palliative care for cancer patients
(more)
Pharmaceutical Journal, 21 Oct 2000, p603-614. Vol 265, no 7119 |
|
(11) Mood disorders: implications for primary care
Mood disorders comprise depression, elation, or a combination
of both. Unipolar disorders are single or recurrent episodes of lowered
mood. Bipolar disorders are episodes of depression alternating with periods
of elation with associated psychotic symptoms. This article explores the
clinical presentation of mood disorders and the public health implications
of these conditions. The drug treatment of depressive disorders and bipolar
disorders will be discussed in two forthcoming articles
(more)
Pharmaceutical Journal, 24 Feb 2001, p259-262. Vol 266, no 7136 |
|
(12) Mood disorders: drug treatment of depression
In this, the second part of our mood disorder feature,
the drug treatment of depression is discussed. The first part (11, above)
covered the clinical presentation and public health implications of mood
disorders. The final part of this feature, to be published at a later
date, will focus on the drug treatment of bipolar disorders
(more)
Pharmaceutical Journal, 31 Mar 2001, p433-441. Vol 266, no 7141 |
|
(13) Mood disorders: Bipolar conditions
In this, the last of three articles on mood disorders,
the treatment of bipolar disorders is considered. Previous articles addressed
the implications of mood disorders for primary care and the treatment
of depression
(PDF 100K)
Pharmaceutical Journal, 16 June 2001, p824-832. Vol 266, no 7152 |
|
(14) Parkinson's disease
This article discusses the clinical features, diagnosis,
treatment and individual patient care of people with Parkinson's disease
(PDF 130K)
Pharmaceutical Journal, 27 October 2001, p600-613. Vol 267, no 7171 |
OTHER ARTICLES
|
|
Pharmaceutical care the German
experience
Pharmaceutical care is developing in several European
countries, but perhaps most visibly in countries such as the Netherlands,
Spain, Denmark, Germany and increasingly in the United Kingdom. In all
countries, pharmaceutical care starts and progresses largely due to the
enthusiasm and efforts of a few individuals and in Germany, the leader
in this field is Professor Marion Schaefer. Pamela Mason travelled to
Germany to speak to her
(more)
Pharmaceutical Journal, 27 Jan 2001, p122-123. Vol 266, no 7132 |
|
What is medicines management and pharmaceutical care?
By Douglas Simpson, editor of the Pharmaceutical Journal
1987 2000
(more)
Pharmaceutical Journal, 3 Feb 2001, p150. Vol 266, no 7133 |
|
A pragmatic way forward
Followup article to "What is medicines management
and pharmaceutical care"
(more)
Pharmaceutical Journal, 3 Mar 2001, p281. Vol 266, no 7137 |
|
Providing pharmaceutical care the views of Scottish pharmacists
Original paper by Dr J Krska and Professor G Veitch
(PDF 85K)
Pharmaceutical Journal, 20 Oct 2001, p549. Vol 267, no 7170 |
|
Pharmaceutical care: where are we now
Speakers from many parts of the world gave their perspectives
on the practice of pharmaceutical care during the Fourth International
Symposium on Innovations in Pharmaceutical care
(more)
Pharmaceutical Journal, 20 Oct 2001, p569-573. Vol 267, no 7170 |
|
Sowing the seeds for pharmaceutical care: developments in undergraduate clinical teaching at Liverpool school of pharmacy
Many schools of pharmacy have made efforts to move away
from the traditional "lectures and laboratories" teaching approach towards
strategies designed to improve both factual recall and professional attitudes
and skills. This article describes how this approach is used to teach
clinical pharmacy and therapeutics and hospital pharmacy at Liverpool
School of Pharmacy and Chemistry
(PDF 60K)
Pharmaceutical Journal, 17 Nov 2001, p721-723. Vol 267, no 7174 |
|
|
Most photographs have been removed
from the PDF files for copyright reasons.
The contents of the Pharmaceutical
Journal, associated publications and all PDF files are the
property of the Royal Pharmaceutical Society. See Copyright for
our rights. |
|
Photocopies
Photocopies of articles can be ordered from the Societys
library (library@rpsgb.org.uk);
for details click here |
|
Reprints
Details on multiple reprints of the original articles are here |
|